BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 38611720)

  • 1. Positive charges promote the recognition of proteins by the chaperone SlyD from Escherichia coli.
    Lindemeier D; Graubner W; Mehner-Breitfeld D; Malešević M; Brüser T
    PLoS One; 2024; 19(6):e0305823. PubMed ID: 38917203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular function of the prolyl cis/trans isomerase and metallochaperone SlyD.
    Kovermann M; Schmid FX; Balbach J
    Biol Chem; 2013 Aug; 394(8):965-75. PubMed ID: 23585180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Periplasmic Chaperones and Prolyl Isomerases.
    Stull F; Betton JM; Bardwell JCA
    EcoSal Plus; 2018 Jul; 8(1):. PubMed ID: 29988001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacterial Chaperone Domain Insertions Convert Human FKBP12 into an Excellent Protein-Folding Catalyst-A Structural and Functional Analysis.
    Žoldák G; Knappe TA; Geitner AJ; Scholz C; Dobbek H; Schmid FX; Jakob RP
    Molecules; 2024 Mar; 29(7):. PubMed ID: 38611720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of the human prolyl isomerase FKBP12 with unrelated chaperone domains leads to chimeric folding enzymes with high activity.
    Geitner AJ; Schmid FX
    J Mol Biol; 2012 Jul; 420(4-5):335-49. PubMed ID: 22542528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insertion of a chaperone domain converts FKBP12 into a powerful catalyst of protein folding.
    Knappe TA; Eckert B; Schaarschmidt P; Scholz C; Schmid FX
    J Mol Biol; 2007 May; 368(5):1458-68. PubMed ID: 17397867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NMR solution structure of SlyD from Escherichia coli: spatial separation of prolyl isomerase and chaperone function.
    Weininger U; Haupt C; Schweimer K; Graubner W; Kovermann M; Brüser T; Scholz C; Schaarschmidt P; Zoldak G; Schmid FX; Balbach J
    J Mol Biol; 2009 Mar; 387(2):295-305. PubMed ID: 19356587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of a highly active folding enzyme by combining a parvulin-type prolyl isomerase from SurA with an unrelated chaperone domain.
    Geitner AJ; Varga E; Wehmer M; Schmid FX
    J Mol Biol; 2013 Nov; 425(22):4089-98. PubMed ID: 23871892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cooperation of the prolyl isomerase and chaperone activities of the protein folding catalyst SlyD.
    Zoldák G; Schmid FX
    J Mol Biol; 2011 Feb; 406(1):176-94. PubMed ID: 21147124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-Based Insights into the Dynamics and Function of Two-Domain SlpA from Escherichia coli.
    Geitner AJ; Weininger U; Paulsen H; Balbach J; Kovermann M
    Biochemistry; 2017 Dec; 56(50):6533-6543. PubMed ID: 29155566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycocerosic acid synthase exemplifies the architecture of reducing polyketide synthases.
    Herbst DA; Jakob RP; Zähringer F; Maier T
    Nature; 2016 Mar; 531(7595):533-7. PubMed ID: 26976449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathways of allosteric regulation in Hsp70 chaperones.
    Kityk R; Vogel M; Schlecht R; Bukau B; Mayer MP
    Nat Commun; 2015 Sep; 6():8308. PubMed ID: 26383706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolyl isomerization and its catalysis in protein folding and protein function.
    Schmidpeter PA; Schmid FX
    J Mol Biol; 2015 Apr; 427(7):1609-31. PubMed ID: 25676311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multidomain Peptidyl Prolyl cis/trans Isomerases.
    Schiene-Fischer C
    Biochim Biophys Acta; 2015 Oct; 1850(10):2005-16. PubMed ID: 25445709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The crystal structure of the phosphatidylinositol 4-kinase IIα.
    Baumlova A; Chalupska D; Róźycki B; Jovic M; Wisniewski E; Klima M; Dubankova A; Kloer DP; Nencka R; Balla T; Boura E
    EMBO Rep; 2014 Oct; 15(10):1085-92. PubMed ID: 25168678
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.